» Authors » Sandrine C Foti

Sandrine C Foti

Explore the profile of Sandrine C Foti including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 469
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Toomey C, Heywood W, Evans J, Lachica J, Pressey S, Foti S, et al.
Acta Neuropathol Commun . 2022 Sep; 10(1):134. PMID: 36076304
Background: The molecular drivers of early sporadic Parkinson's disease (PD) remain unclear, and the presence of widespread end stage pathology in late disease masks the distinction between primary or causal...
2.
Miki Y, Tanji K, Shinnai K, Tanaka M, Altay F, Foti S, et al.
Neuropathol Appl Neurobiol . 2022 Jul; 48(7):e12844. PMID: 35906771
Aims: Synaptic dysfunction in Parkinson's disease is caused by propagation of pathogenic α-synuclein between neurons. Previously, in multiple system atrophy (MSA), pathologically characterised by ectopic deposition of abnormal α-synuclein predominantly...
3.
Miki Y, Tsushima E, Foti S, Strand K, Asi Y, Yamamoto A, et al.
Brain . 2021 Apr; 144(4):1138-1151. PMID: 33822892
We studied a subset of patients with autopsy-confirmed multiple system atrophy who presented a clinical picture that closely resembled either Parkinson's disease or progressive supranuclear palsy. These mimics are not...
4.
Bettencourt C, Miki Y, Piras I, de Silva R, Foti S, Talboom J, et al.
Neuropathol Appl Neurobiol . 2020 Dec; 47(5):640-652. PMID: 33368549
Aims: Multiple system atrophy (MSA) is a fatal neurodegenerative disease. Similar to Parkinson's disease (PD), MSA is an α-synucleinopathy, and its pathological hallmark consists of glial cytoplasmic inclusions (GCIs) containing...
5.
Low Y, Asi Y, Foti S, Lashley T
Mol Neurobiol . 2020 Oct; 58(2):631-646. PMID: 33000450
Heterogenous nuclear ribonucleoproteins (hnRNPs) are a complex and functionally diverse family of RNA binding proteins with multifarious roles. They are involved, directly or indirectly, in alternative splicing, transcriptional and translational...
6.
Bettencourt C, Piras I, Foti S, Talboom J, Miki Y, Lashley T, et al.
Acta Neuropathol Commun . 2020 May; 8(1):71. PMID: 32410669
No abstract available.
7.
Miki Y, Foti S, Hansen D, Strand K, Asi Y, Tsushima E, et al.
Brain . 2020 May; 143(6):1798-1810. PMID: 32385496
Recent post-mortem studies reported 22-37% of patients with multiple system atrophy can develop cognitive impairment. With the aim of identifying associations between cognitive impairment including memory impairment and α-synuclein pathology,...
8.
Shibata-Germanos S, Goodman J, Grieg A, Trivedi C, Benson B, Foti S, et al.
Acta Neuropathol . 2019 Nov; 139(2):383-401. PMID: 31696318
The vertebrate CNS is surrounded by the meninges, a protective barrier comprised of the outer dura mater and the inner leptomeninges, which includes the arachnoid and pial layers. While the...
9.
Bettencourt C, Foti S, Miki Y, Botia J, Chatterjee A, Warner T, et al.
Acta Neuropathol . 2019 Sep; 139(1):135-156. PMID: 31535203
Multiple system atrophy (MSA) is a fatal late-onset neurodegenerative disease. Although presenting with distinct pathological hallmarks, which in MSA consist of glial cytoplasmic inclusions (GCIs) containing fibrillar α-synuclein in oligodendrocytes,...
10.
Miki Y, Foti S, Asi Y, Tsushima E, Quinn N, Ling H, et al.
Brain . 2019 Jul; 142(9):2813-2827. PMID: 31289815
Clinical diagnosis of multiple system atrophy is challenging and many patients with Lewy body disease (i.e. Parkinson's disease or dementia with Lewy bodies) or progressive supranuclear palsy are misdiagnosed as...